A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/29/2004	WO2004112838A2 Codrugs of diclofenac
12/29/2004	WO2004112837A1 PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1α PRODUCTION INHIBITOR
12/29/2004	WO2004112829A2 Compositions and methods for the diagnosis and treatment of tumors of glial origin
12/29/2004	WO2004112816A1 Fermentation product and process for producing the same
12/29/2004	WO2004112815A1 Melanogenesis promoter and melanogenesis promoter composition
12/29/2004	WO2004112813A1 Litchi sinensis extracts containing oligomeric proanthocyanidins
12/29/2004	WO2004112810A1 Pharmaceutical compositions for antidiarrhea
12/29/2004	WO2004112805A1 Antimicrobial silver comprising silver
12/29/2004	WO2004112804A1 Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
12/29/2004	WO2004112803A1 Methods of managing the symptoms of premenstrual syndrome
12/29/2004	WO2004112802A1 Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (siv) and transmissible gastroenteritis coronavirus (tgev)
12/29/2004	WO2004112801A2 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
12/29/2004	WO2004112800A1 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
12/29/2004	WO2004112799A1 Methods and apparatus for producing nanoscale particles
12/29/2004	WO2004112798A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase
12/29/2004	WO2004112797A1 Hormone replacement- and depression therapy comprising dienogest
12/29/2004	WO2004112796A1 Treatment of amd with combination of ingredients
12/29/2004	WO2004112795A1 Ltb4 compositions for treating tract infections
12/29/2004	WO2004112794A2 New pharmaceutical uses of staurosporine derivatives
12/29/2004	WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/29/2004	WO2004112792A1 The medical use of 11,11`-dideoxyverticillin a
12/29/2004	WO2004112791A1 Therapeutic and/or preventive agent for lung disease
12/29/2004	WO2004112790A1 Sponge toxins
12/29/2004	WO2004112789A1 Ophthalmic composition
12/29/2004	WO2004112788A1 Pyridoxamine for the treatment of diabetic kidney disease
12/29/2004	WO2004112787A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/29/2004	WO2004112786A2 Gaboxadol for treating depression and other affective disorders
12/29/2004	WO2004112785A1 New use iii
12/29/2004	WO2004112784A1 New use i
12/29/2004	WO2004112783A1 New use iv
12/29/2004	WO2004112782A1 New use v
12/29/2004	WO2004112781A1 New use ii
12/29/2004	WO2004112780A1 Metronidazole-based green tinted topical pharmaceutical composition
12/29/2004	WO2004112779A1 New use vii
12/29/2004	WO2004112778A1 Cisplatin preparation and process for producing the same
12/29/2004	WO2004112777A1 Composition for prevention/treatment for varicose vein
12/29/2004	WO2004112776A2 Inflammatory disease treatment
12/29/2004	WO2004112775A1 Composition for preventing urinary system infections
12/29/2004	WO2004112773A1 Pharmaceutical compositions used for immune disease treatment and improvement
12/29/2004	WO2004112772A1 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
12/29/2004	WO2004112771A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof
12/29/2004	WO2004112770A1 Adhesive patch containing tulobuterol
12/29/2004	WO2004112769A1 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
12/29/2004	WO2004112768A1 Memantine oral dosage forms
12/29/2004	WO2004112767A1 Improved absorption of fat-soluble nutrients
12/29/2004	WO2004112766A1 Composition for lowering blood glucose
12/29/2004	WO2004112765A1 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol
12/29/2004	WO2004112764A1 Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same
12/29/2004	WO2004112763A2 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure
12/29/2004	WO2004112762A2 Pharmaceutical formulations of amyloid inhibiting compounds
12/29/2004	WO2004112761A2 Stable 5, 10-methylene-tetrahydrofolate pharmaceutical compounds
12/29/2004	WO2004112757A1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug
12/29/2004	WO2004112756A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
12/29/2004	WO2004112754A1 Flupirtin injectable galenic form
12/29/2004	WO2004112753A1 Pharmaceutical compositions based on diclofenac derivate
12/29/2004	WO2004112751A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
12/29/2004	WO2004112730A2 Method and compositions for treating tumors
12/29/2004	WO2004112725A2 Methods for inhibiting or reversing tau filament fibrillization
12/29/2004	WO2004112723A2 Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
12/29/2004	WO2004112719A2 Chemical compounds
12/29/2004	WO2004112716A2 Prodrugs of heteroaryl compounds
12/29/2004	WO2004112715A2 Methods of making and using theaflavin,theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’ - digallate and mixtures thereof
12/29/2004	WO2004112714A2 Chemical compounds
12/29/2004	WO2004112710A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
12/29/2004	WO2004112709A2 Inhibitors of cathepsin s
12/29/2004	WO2004112706A2 Vaccines, immunotherapeutics and methods for using the same
12/29/2004	WO2004112701A2 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	WO2004112699A2 Mitotic kinesin inhibitors
12/29/2004	WO2004112696A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases
12/29/2004	WO2004112695A2 Methods and compositions for delivery of catecholic butanes for treatment of obesity
12/29/2004	WO2004112687A2 Antiviral acylguanidine compounds and methods
12/29/2004	WO2004112512A1 Amino acid supplementation for a healthy microbiota ecosystem
12/29/2004	WO2004112510A1 Movement physiology improver
12/29/2004	WO2004112505A1 Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things
12/29/2004	WO2004101767A3 Cbi analogues of the duocarmycins and cc-1065
12/29/2004	WO2004098713A3 Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)
12/29/2004	WO2004098578A3 Composition comprising a pde4 inhibitor and a tnf-alfa antagonist selected from infliximab, adalimumab, cdp870 and cdp517
12/29/2004	WO2004096828A3 Novel method and intermediates for the preparation of 19-nor-steroid compounds
12/29/2004	WO2004093832A3 Cosmetic or pharmaceutical composition comprising a combination of at least one diacylglycerol and at least one fatty alcohol
12/29/2004	WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor
12/29/2004	WO2004092146A3 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
12/29/2004	WO2004091512A3 Abuse-resistant oral dosage forms and method of use thereof
12/29/2004	WO2004091502A3 1,2,4-oxadiazole benzoic acid compounds
12/29/2004	WO2004089964A8 Lipid-regulating agent and use thereof
12/29/2004	WO2004089357A3 Anti-fungal formulation of triterpene and essential oil
12/29/2004	WO2004089334A3 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
12/29/2004	WO2004085396A8 Preventive or therapeutic agent for ischemia/reperfusion injury, organ preservative, and screening method
12/29/2004	WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
12/29/2004	WO2004084932A3 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
12/29/2004	WO2004084920A3 Anti-inflammatory treatment based on strontium compounds
12/29/2004	WO2004084880B1 METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
12/29/2004	WO2004082630A3 High potency dopaminergic treatment of neurological impairment associated with brain injury
12/29/2004	WO2004082618A3 Synthesis of 5-azacytidine
12/29/2004	WO2004080415A3 Gel composition and method for treatment of vaginal infections
12/29/2004	WO2004078714A3 Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazouinoxalines and heterocyclic-substituted imidazopyrazines
12/29/2004	WO2004078157A3 Regulation of mammalian hair growth
12/29/2004	WO2004078119A3 Substituted thiophenes with antibacterial activity
12/29/2004	WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors
12/29/2004	WO2004075853A3 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/29/2004	WO2004075815A3 Diarylcycloalkyl derivatives, method for their production and their use as medicaments

1 ... 4840 4841 4842 4843 4844 4845 4846 4847 4848 4849 4850 4851 4852 4853 4854 4855 4856 4857 4858 4859 4860 ... 7860